Rapid Clinical Improvement of Anti-HMGCR Immune-mediated Necrotizing Myopathy (IMNM) Treated with Efgartigimod (P3-11.015)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000210911
Citations
1
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rapid Clinical Improvement of Anti-HMGCR Immune-mediated Necrotizing Myopathy (IMNM) Treated with Efgartigimod (P3-11.015)

Li Zeng, Kai Chen, Quantao Zeng, Lixia Xu et al.
1 citations
Neurology
Inflammatory Myopathies and Dermatomyositis
1.35
article

Rapid Clinical Improvement of Anti-HMGCR Immune-mediated Necrotizing Myopathy (IMNM) Treated with Efgartigimod (P3-11.015)

Li Zeng, Kai Chen, Quantao Zeng, Lixia Xu, Song Tan
article en
1 citations

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
Fourth People's Hospital of Sichuan Province (CN)
Openalex Percentile: Top 21%
Inflammatory Myopathies and Dermatomyositis
1.35
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Rapid Clinical Improvement of Anti-HMGCR Immune-mediated Necrotizing Myopathy (IMNM) Treated with Efgartigimod (P3-11.015) — Li Zeng, Kai Chen, et al. · Neurology (2025) | TGRS Research Map | TGRS